COZ Stock Chart & Stats
CHF62.32
CHF0.00(0.00%)
At close: 4:00 PM EDT
CHF62.32
CHF0.00(0.00%)
Day’s Range― - ―
52-Week RangeCHF62.32 - CHF62.32
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
CHF21.45B
Enterprise ValueCHF19.09B
Total Cash (Recent Filing)CHF1.05B
Total Debt (Recent Filing)CHF2.09B
Price to Earnings (P/E)12.2
BetaN/A
Next Earnings
Oct 29, 2026EPS Estimate
1.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.66
Shares Outstanding450,444,200
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio20.57
Price to Book (P/B)2.66
Price to Sales (P/S)1.89
P/FCF Ratio15.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF54.70Price Target Upside-12.23% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering19
EPS Forecast (FY)4.8
Revenue Forecast (FY)CHF18.48B
Bulls Say, Bears Say
Bulls Say
Low LeverageVery low leverage gives Cognizant financial flexibility through business cycles and reduces dependence on external funding. A strong equity base supports continued investment, acquisitions, and shareholder returns while limiting the balance-sheet strain that can accompany enterprise technology spending volatility.
Strong Cash GenerationRobust free cash flow and high conversion indicate that reported earnings are translating into usable cash. This supports acquisitions, technology investment, dividends, and repurchases while providing an internal funding source for growth and resilience over the next several quarters.
AI And Platform ExpansionBroad AI adoption within delivery operations can improve productivity while expanding Cognizant’s relevance in modernization and automation programs. Its AI operating system, market unit, partnerships, and platform capabilities may also deepen client relationships and support higher-value recurring work.
Bears Say
Margin CompressionHistorical margin compression suggests that pricing, cost, or service-mix pressures have not been fully eliminated. If these forces persist, revenue growth may translate less efficiently into earnings and reduce the resources available for reinvestment, acquisitions, and shareholder returns.
Cautious Enterprise DemandCautious client spending can delay consulting, modernization, and discretionary technology programs, limiting organic growth across several industries. Although the guidance still implies expansion, sustained budget scrutiny could lengthen sales cycles, constrain project volumes, and make growth more dependent on acquisitions.
Working Capital And Financing CostsHigher receivables days can delay cash realization and create volatility in operating cash flow even when revenue and earnings grow. The revolver draw also raises interest costs and reduces financial flexibility, making cash conversion and disciplined capital allocation more important over coming quarters.
COZ FAQ
What was Cognizant Technology Solutions’s price range in the past 12 months?
Cognizant Technology Solutions lowest stock price was CHF62.32 and its highest was CHF62.32 in the past 12 months.
What is Cognizant Technology Solutions’s market cap?
Cognizant Technology Solutions’s market cap is CHF21.45B.
When is Cognizant Technology Solutions’s upcoming earnings report date?
Cognizant Technology Solutions’s upcoming earnings report date is Oct 29, 2026 which is in 21 days.
How were Cognizant Technology Solutions’s earnings last quarter?
Cognizant Technology Solutions released its earnings results on Jul 29, 2026. The company reported CHF1.14 earnings per share for the quarter, missing the consensus estimate of CHF1.146 by -CHF0.006.
Is Cognizant Technology Solutions overvalued?
According to Wall Street analysts Cognizant Technology Solutions’s price is currently Overvalued.
Does Cognizant Technology Solutions pay dividends?
Cognizant Technology Solutions does not currently pay dividends.
What is Cognizant Technology Solutions’s EPS estimate?
Cognizant Technology Solutions’s EPS estimate is 1.22.
How many shares outstanding does Cognizant Technology Solutions have?
Cognizant Technology Solutions has 450,444,200 shares outstanding.
What happened to Cognizant Technology Solutions’s price movement after its last earnings report?
Cognizant Technology Solutions reported an EPS of CHF1.14 in its last earnings report, missing expectations of CHF1.146. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cognizant Technology Solutions?
Currently, no hedge funds are holding shares in CH:COZ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cognizant Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
CHF54.70 (-12.23% Downside)
CHF54.70 (-12.23% Downside)
Blogger Sentiment
Bullish
CH:COZ Sentiment 100%
Sector Average 64%
Sector Average 64%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-14.10%
12-Months-Change
Fundamentals
Return on Equity
14.94%
Trailing 12-Months
Asset Growth
3.28%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cognizant Technology Solutions
Cognizant Technology Solutions Corporation functions as a global professional services firm, delivering a comprehensive suite of consulting, technology, and outsourcing solutions across North America, Europe, and other international markets. Its operations are structured into four primary divisions: Financial Services, Healthcare, Products and Resources, and Communications, Media and Technology. Within the Financial Services sector, Cognizant provides advanced services such as enhancing customer experiences, implementing robotic process automation (RPA), and leveraging analytics and artificial intelligence (AI) to address needs in areas like digital lending, fraud prevention, and modern payment systems. For its Healthcare clients, the company focuses on navigating industry shifts toward consumer-centric models, outcome-based agreements, and digital health initiatives, striving to deliver an integrated, seamless, and patient-focused omnichannel experience. Furthermore, Cognizant assists in optimizing operations across various functions, including clinical development, pharmacovigilance, manufacturing, claims management, enrollment procedures, membership administration, and billing processes. Its clientele in this domain spans healthcare providers, payers, and life sciences organizations, encompassing pharmaceutical, biotechnology, and medical device firms. In the Products and Resources segment, the company develops solutions tailored for manufacturers, retailers, and entities within the travel and hospitality sectors, alongside those engaged in logistics, energy, and utility services. Within the Communications, Media and Technology division, Cognizant supports businesses in creating digital content, crafting personalized user experiences, and expediting digital engineering efforts. This includes serving information, media, entertainment, communications, and technology enterprises. Established in 1994, the company maintains its primary corporate office in Teaneck, New Jersey.
COZ Company Deck
COZ Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a predominantly positive operational and strategic picture: revenue growth, margin expansion, strong bookings and large‑deal momentum (particularly in financial services), accelerated AI adoption and platform initiatives, meaningful share repurchases, and healthy free cash flow. Notable near‑term headwinds include Project LEAP costs, India labor reforms run‑rate impacts, higher interest expense from revolver use for acquisitions and buybacks, higher DSO, some industry pockets of muted demand, and observable AI execution/ROI challenges across a portion of the Global 2000. On balance, the positive growth, margin recovery, and AI‑led strategy and execution appear to outweigh the lowlights.View all CH:COZ earnings summariesCOZ Revenue Breakdown
30.06% Health Sciences
29.15% Financial Services
24.23% Products and Resources
16.56% Communications, Media and Technology

COZ Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
CHF54.70
▼(-12.23% Downside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month












